Harvard Apparatus Regenerative Technology Management
Management criteria checks 2/4
Harvard Apparatus Regenerative Technology's CEO is Jerry He, appointed in Mar 2023, has a tenure of 1.83 years. total yearly compensation is $5.87M, comprised of 6.6% salary and 93.4% bonuses, including company stock and options. directly owns 1.65% of the company’s shares, worth $711.80K. The average tenure of the management team and the board of directors is 4.8 years and 4 years respectively.
Key information
Jerry He
Chief executive officer
US$5.9m
Total compensation
| CEO salary percentage | 6.6% |
| CEO tenure | 1.8yrs |
| CEO ownership | 1.6% |
| Management average tenure | 4.8yrs |
| Board average tenure | 4yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$8m |
| Jun 30 2024 | n/a | n/a | -US$8m |
| Mar 31 2024 | n/a | n/a | -US$8m |
| Dec 31 2023 | US$6m | US$390k | -US$9m |
| Sep 30 2023 | n/a | n/a | -US$9m |
| Jun 30 2023 | n/a | n/a | -US$8m |
| Mar 31 2023 | n/a | n/a | -US$7m |
| Dec 31 2022 | US$45k | n/a | -US$6m |
| Sep 30 2022 | n/a | n/a | -US$11m |
| Jun 30 2022 | n/a | n/a | -US$10m |
| Mar 31 2022 | n/a | n/a | -US$9m |
| Dec 31 2021 | US$45k | n/a | -US$8m |
Compensation vs Market: Jerry's total compensation ($USD5.87M) is above average for companies of similar size in the US market ($USD642.68K).
Compensation vs Earnings: Jerry's compensation has increased whilst the company is unprofitable.
CEO
Jerry He (50 yo)
1.8yrs
Tenure
US$5,872,638
Compensation
Mr. Junli He, also known as Jerry, serves as Director of Harvard Apparatus Regenerative Technology Inc. (formerly known as Biostage, Inc.) since September 01, 2021 and serves as its Chief Executive Officer...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Chairman | 1.8yrs | US$5.87m | 1.65% $ 711.8k | |
| President | 6.7yrs | US$189.07k | 1.68% $ 725.3k | |
| Chief Financial Officer | 2.4yrs | US$266.04k | 0% $ 0 | |
| Chief Scientific Officer | 7.5yrs | US$245.07k | 0% $ 0 | |
| Vice President of Business Development & Operations | 4.8yrs | no data | no data |
4.8yrs
Average Tenure
50.5yo
Average Age
Experienced Management: HRGN's management team is considered experienced (4.8 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Chairman | 3.3yrs | US$5.87m | 1.65% $ 711.8k | |
| Independent Director | 1.8yrs | US$70.00k | 0% $ 0 | |
| Director | 3.2yrs | US$4.65m | 1.1% $ 476.3k | |
| Chairman of Scientific Advisory Board | 2yrs | no data | no data | |
| Independent Director | 6.8yrs | US$45.00k | 0.11% $ 45.9k | |
| Member of Scientific Advisory Board | 6.9yrs | no data | no data | |
| Independent Vice Chairman | 6.9yrs | US$45.00k | 1.01% $ 438.7k | |
| Member of Scientific Advisory Board | 7yrs | no data | no data | |
| Independent Director | 6.2yrs | US$45.00k | 0% $ 0 | |
| Independent Director | 4yrs | US$45.00k | 0% $ 0 | |
| Independent Director | less than a year | no data | no data |
4.0yrs
Average Tenure
60yo
Average Age
Experienced Board: HRGN's board of directors are considered experienced (4 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/06 07:40 |
| End of Day Share Price | 2025/01/03 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Harvard Apparatus Regenerative Technology Inc. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jason Kolbert | Maxim Group |
| Pamela Bassett | Maxim Group |